Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (13e,15s)-15-hydroxy-9-oxo-prosta-10,13-dien-1-oic Acid
2. Pga1
3. Prostaglandin A1, (13e,15r)-(+-)-isomer
4. Prostaglandin A1, (13e,15r)-isomer
5. Prostaglandin A1, (13e,15s)-(+-)-isomer
6. Prostaglandin A1, (8beta,12alpha,13e,15s)-isomer
1. Pga1
2. 14152-28-4
3. Prosta-10,13-dien-1-oic Acid, 15-hydroxy-9-oxo-, (13e,15s)-
4. Pga1 (prostaglandin A1)
5. 15a-hydroxy-9-oxo-10,13e-prostadienoate
6. Vyr271n44p
7. (13e,15s)-15-hydroxy-9-oxoprosta-10,13-dien-1-oic Acid
8. Chebi:15545
9. 15a-hydroxy-9-oxo-10,13e-prostadienoic Acid
10. 7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoic Acid
11. 9-oxo-15s-hydroxy-10z,13e-prostadienoic Acid
12. Pga(sub 1)
13. Pga(sup 1)
14. Prostaglandin A(sub 1)
15. Prostaglandin A(sup 1)
16. Prostaglandin E1-217
17. Prostaglandin E(sup 1)-217
18. Chembl1084644
19. Unii-vyr271n44p
20. 3-cyclopentene-1-heptanoic Acid, 2-(3-hydroxy-1-octenyl)-5-oxo-
21. Prostaglandin A1, Synthetic
22. Bspbio_001458
23. Bml1-f01
24. Schembl6417548
25. Eicosanoids_pga1_c20h32o4
26. Pga1, Prostaglandin A1, Powder
27. Prostaglandin A1 (pga1)
28. Dtxsid601347314
29. Hms1361i20
30. Hms1791i20
31. Hms1989i20
32. Hms3402i20
33. Hms3648a03
34. Prostaglandin A1 [usp-rs]
35. (13e,15s)-15-hydroxy-9-oxo-prosta-10,13-dien-1-oic Acid
36. Zinc4096507
37. Lmfa03010005
38. Ccg-208253
39. Idi1_033928
40. Ncgc00161282-01
41. Ncgc00161282-02
42. Ncgc00161282-03
43. 15-hydroxy-9-oxoprosta-10,13-dienoate
44. 15a-hydroxy-9-ketoprosta-10,13-dienoate
45. 15-hydroxy-9-oxoprosta-10,13-dienoic Acid
46. Alprostadil Impurity A [ep Impurity]
47. 15a-hydroxy-9-ketoprosta-10,13-dienoic Acid
48. Sr-01000946186
49. J-007508
50. Sr-01000946186-1
51. Brd-k04010869-001-02-6
52. Q27098093
53. (13e,15s)-15-hydroxy-9-oxo-prosta-10,13-dien-1-oate
54. 9-oxo-15s-hydroxy-prosta-10,13e-dien-1-oic Acid
55. 2-(3-hydroxy-1-octenyl)-5-oxo-3- Cyclopentene-1-heptanoate
56. 2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopentene-1-heptanoate
57. 2-(3-hydroxy-1-octenyl)-5-oxo-3- Cyclopentene-1-heptanoic Acid
58. 2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopentene-1-heptanoic Acid
59. Pga1 (prostaglandin A1) Is Known As A Cyclopentenone Prostaglandin.
60. Prostaglandin A1, United States Pharmacopeia (usp) Reference Standard
61. 7-((1r,2s)-2-((s,e)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)heptanoic Acid
62. 7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]heptanoic Acid
Molecular Weight | 336.5 g/mol |
---|---|
Molecular Formula | C20H32O4 |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 13 |
Exact Mass | 336.23005950 g/mol |
Monoisotopic Mass | 336.23005950 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 439 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Prostaglandin A1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prostaglandin A1, including repackagers and relabelers. The FDA regulates Prostaglandin A1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prostaglandin A1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prostaglandin A1 supplier is an individual or a company that provides Prostaglandin A1 active pharmaceutical ingredient (API) or Prostaglandin A1 finished formulations upon request. The Prostaglandin A1 suppliers may include Prostaglandin A1 API manufacturers, exporters, distributors and traders.
Prostaglandin A1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prostaglandin A1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prostaglandin A1 GMP manufacturer or Prostaglandin A1 GMP API supplier for your needs.
A Prostaglandin A1 CoA (Certificate of Analysis) is a formal document that attests to Prostaglandin A1's compliance with Prostaglandin A1 specifications and serves as a tool for batch-level quality control.
Prostaglandin A1 CoA mostly includes findings from lab analyses of a specific batch. For each Prostaglandin A1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prostaglandin A1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Prostaglandin A1 EP), Prostaglandin A1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prostaglandin A1 USP).
LOOKING FOR A SUPPLIER?